CVD in Asian Americans: What clinicians need to know and do differently

Heart disease is a bigger problem in Asian American communities than many realize — and standard clinical tools aren't keeping up. Over half of Asian American men and nearly 40% of women are living with CVD, including coronary artery disease, heart failure, and stroke. On top of that, Asian populations have the highest rate of undiagnosed diabetes in the U.S., with more than 50% of Asians with diabetes unaware of their condition due to lack of screening.

The problem is compounded by a one-size-fits-all approach to care. Standard CVD risk calculators significantly underestimate risk in these populations, and treatment responses vary widely across subgroups — for example, many East Asians metabolize statins more slowly, raising their risk for serious side effects like rhabdomyolysis.

Key Takeaways

• Screen Asian patients for diabetes starting at BMI ≥23 kg/m², not the standard 25 kg/m²
• Up to 90% of Pacific Islanders carry a CYP2C19 loss-of-function allele, making clopidogrel ineffective — alternative antiplatelet therapy should be considered
• South Asians develop coronary artery disease up to 10 years earlier than those of European descent
• Disaggregating data by specific ethnicity (not just "Asian") is critical for accurate diagnosis and management

Why it matters: Asian Americans, Native Hawaiians, and Pacific Islanders are among the fastest-growing populations in the U.S., yet they remain underserved by clinical guidelines built around other demographics. Tailoring screening thresholds, medication choices, and dietary counseling to these communities could prevent thousands of delayed diagnoses and avoidable cardiovascular events.